PRINCETON, N.J., Sept. 1 (HSMN NewsFeed) — Celator Pharmaceuticals, a privately held clinical laboratory company developing new and more effective therapies to treat cancer based on the company’s proprietary technology, today announced that it raised $20 mil…
Biopharmaceuticals, Venture Capital
Celator Pharmaceuticals

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Celator(R) Pharmaceuticals Raises $20 Million in Series D Financing”
Leave a Comment